Volta Labs and Watchmaker Genomics Partner to Simplify and Optimize NGS Library Prep

Partnership

Volta Labs, a genomics applications company, and Watchmaker Genomics, a supplier of innovative products for molecular analysis, partner to leverage their technologies to power Volta’s short-read library prep kits.

Committment

Volta Labs and Watchmaker Genomics are jointly committed to making efficient, accessible, and cost-effective library prep a reality. With the launch of Volta’s Callisto™ Sample Prep System, Watchmaker Genomics will provide the reagents behind various VoltaPrep™ library prep kits.

Trey Foskett, CEO of Watchmaker Genomics

“Volta’s digital fluidics technology and their approach to building automated sample prep applications are impressive. Watchmaker has a passion for delivering superior data quality with simple and automatable workflows. Combining Volta’s cutting-edge technology with our innovative reagents delivers in both of these areas, and we look forward to a continued partnership.”

Udayan Umapathi, CEO at Volta Labs

“Watchmaker has set the bar high for enzyme engineering and library prep workflow development. We are energized to work with their talented team to address quality, cost, and scalability challenges that currently exist in sample prep. This collaboration is the first in a series of Volta applications that will be powered by Watchmaker chemistry.”

Callisto™ Sample Prep System

The Callisto™ Sample Prep System offers programmable, precise, and plastic-free liquid manipulation with pre-optimized applications to support short- and long-read sequencing workflows. With a growing menu of library prep kits powered by Watchmaker Genomics’ solutions, Volta will continue to expand the universe of pre-optimized applications available through Callisto and enable labs to maximize advancements in sequencing.

Sourceolta Labs

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.